Hepatic CREBH overexpression resulted in potent reductions in body weight and adiposity, improvements in glucose homeostasis, and reversal of hepatic steatosis in high-fat diet (HFD)–fed mice. The gene discussed is CREB3L3; the disease is fatty liver disease.